Christopher Ballas

Senior Vice President, Manufacturing • Innovative Cellular Therapeutics

Over 20 years’ experience of working on cell and gene therapies in academic and industry roles with expertise in manufacturing of viral vectors and cell therapies.

Served as Vice President of Manufacturing for publicly traded Rocket Pharmaceuticals, and prior to that as Senior Director of Process Development and Commercialization for publicly traded WuXi AppTec, where he was responsible for manufacturing operations and program management for gene therapy clients.

Previously ran autologous cell therapy clinical trials for Cook Medical, and held key positions for cell and gene therapy core programs at Indiana University School of Medicine. Co-developed ultra-high throughput microinjection device (US9885059) and co-founded Basilard Biotech to commercialize this technology.

Holds a Ph.D. in Cellular and Molecular Pathology from Vanderbilt University School of Medicine and was a Children’s Brittle Bone Foundation fellow during a post-doctoral fellowship at Case Western Reserve University School of Medicine.

Also Speaking

Joseph Micsko

Global Director, Process Manufacturing Technology • CAI

Nina Bauer

Senior Director, Head of Commercial, Gene Therapy • MilliporeSigma

Leisha Kopp

Applications Scientist • Mirus Bio

Event Info


Fun Run